Table 3.
Dietary biomarkers comparing intervention to control at baseline and 6-month follow-up in the Dietary Intervention in Bladder Cancer Study (DIBS).
Baseline | 6-month Follow-up | p-valuec | |||
---|---|---|---|---|---|
Control Mean (SE) | Intervention Mean (SE) | Control Mean (SE) | Intervention Mean (SE) | ||
| |||||
N = 18 | N = 30 | N = 15 | N = 24 | ||
| |||||
Lutein plus zeaxanthin (umol/L) a | 0.38 (0.04)‡ | 0.33 (0.07)‡ | 0.37 (0.03) | 0.32 (0.05) | 0.97 |
Cryptoxanthin (umol/L) a | 0.19 (0.04) | 0.19 (0.06)* | 0.18 (0.04) | 0.13 (0.03)* | 0.42 |
Lycopene (umol/L) a | 0.78 (0.06) | 0.65 (0.06) | 0.76 (0.11) | 0.68 (0.08) | 0.38 |
Alpha-carotene (umol/L) a | 0.20 (0.03)‡ | 0.14 (0.04)‡** | 0.17 (0.03) | 0.16 (0.03)** | 0.03 |
Beta-carotene (umol/L) a | 0.62 (0.09)‡ | 0.47 (0.09)‡ | 0.69 (0.16) | 0.55 (0.08) | 0.40 |
Total carotenoids (umol/L) a | 2.2 (0.18)‡ | 1.70 (0.19)‡ | 2.2 (0.29) | 1.80 (0.20) | 0.60 |
Isothiocyanate (umol/L) b | 95.5 (42.9) | 40.0 (14.4) | 56.9 (23.0) | 59.9 (14.8) | 0.32 |
Plasma
Urine
p-value based on Wilcoxon rank sum test comparing changes in each marker between groups.
between group difference at baseline Wilcoxon test p-value < 0.1
between group difference at baseline Wilcoxon test p-value < 0.05
within group change p-value < 0.1
within group change p-value < 0.05